Early Life and Education
Julian Baker was born in 1965 and is 59 years old. He earned an A.B. Magna Cum Laude from Harvard University.
Rise to Success
Baker's professional journey began at Credit Suisse First Boston Corporation's private equity investment arm from 1988 to 1993. In 1994, he and his brother, Felix Baker, started managing healthcare investments for the Laurence Tisch family. In 2000, the brothers co-founded Baker Brothers Advisors (BBA), a hedge fund specializing in biotechnology stocks. BBA has become a leading biotechnology investor with over $20 billion in assets under management as of March 2024. Baker's investment strategy has led to significant returns, with Yale University's charitable foundation's investment with BBA growing from $274 million in 2009 to $1.08 billion by 2016.
Key Business Strategies
Baker Brothers Advisors focuses on the biotechnology sector, emphasizing long-term investments in publicly traded life sciences companies. The firm's strategy involves deep research and analysis within the healthcare industry, identifying and investing in companies with promising growth potential. BBA maintains a secretive approach, avoiding press and public comments, allowing them to focus on their investment strategy. Baker also serves on boards of several public and private companies, including Madrigal Pharmaceuticals, Incyte Pharmaceuticals, Denali Therapeutics, and Acadia Pharmaceuticals.
Philanthropy
Julian Baker is involved in philanthropic activities through The J Baker Foundation, which supports various organizations through grants and donations. The foundation's grant-making history is public information, it made grants of $3,009,600 in 2024.